This company has been marked as potentially delisted and may not be actively trading. AcelRx Pharmaceuticals (ACRX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Talphera’s Strategic Rebrand and Niyad’s Market Potential Bolster Buy RatingJanuary 11, 2024 | markets.businessinsider.comAcelRx announces rebranding with name change to TalpheraJanuary 9, 2024 | msn.comAcelRx Announces Rebranding With Name Change to Talphera, Inc.January 9, 2024 | finance.yahoo.comAcelRx Pharmaceuticals Stock (NASDAQ:ACRX) Dividends: History, Yield and DatesDecember 22, 2023 | benzinga.comAcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United StatesDecember 12, 2023 | finance.yahoo.comAcelRx Pharmaceuticals files for $150M mixed shelfNovember 22, 2023 | msn.comAcelRx Pharmaceuticals, Inc.: AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 9, 2023 | finanznachrichten.deAcelRx Pharmaceuticals Q3 2023 Earnings PreviewNovember 7, 2023 | msn.comAcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical StudyNovember 7, 2023 | finance.yahoo.comAcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023October 26, 2023 | finance.yahoo.comAcelRx Receives IDE Approval for Niyad and Advances to a Single Registration StudyOctober 3, 2023 | finance.yahoo.comAcelRx CEO buys 10,000 sharesSeptember 12, 2023 | msn.comInsider Buying: CEO Vincent Angotti Acquires 10,000 Shares of AcelRx Pharmaceuticals IncSeptember 12, 2023 | finance.yahoo.comWhat Makes AcelRx Pharmaceuticals (ACRX) a New Buy StockAugust 22, 2023 | finance.yahoo.comPositive Report for Acelrx (ACRX) from H.C. WainwrightAugust 18, 2023 | markets.businessinsider.comAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call TranscriptAugust 13, 2023 | finance.yahoo.comAcelRx Pharmaceuticals, Inc.: AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 12, 2023 | finanznachrichten.deQ2 2023 AcelRx Pharmaceuticals Inc Earnings CallAugust 11, 2023 | finance.yahoo.comAcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 11, 2023 | finance.yahoo.comAcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Tops Revenue EstimatesAugust 11, 2023 | finance.yahoo.comAcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023July 28, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq RulesJuly 21, 2023 | finance.yahoo.comAcelRx Pharmaceuticals launches ~$10M private placement of sharesJuly 18, 2023 | seekingalpha.comAcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesJuly 18, 2023 | finance.yahoo.comACRX - AcelRx Pharmaceuticals, Inc.June 17, 2023 | finance.yahoo.comAcelRx Pharmaceuticals (NASDAQ: ACRX)June 16, 2023 | fool.comAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 13, 2023 | finanznachrichten.deRecap: AcelRx Pharmaceuticals Q1 EarningsMay 11, 2023 | msn.comAcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1May 10, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 10, 2023 | finance.yahoo.comEarnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q1 Earnings Expected to DeclineMay 4, 2023 | finance.yahoo.comAcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseMay 3, 2023 | msn.comAcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023April 27, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora PharmaceuticalsApril 5, 2023 | finance.yahoo.comAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q4 2022 Earnings Call TranscriptApril 4, 2023 | finance.yahoo.comAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate UpdateMarch 31, 2023 | finanznachrichten.deAcelrx (ACRX) Receives a Hold from H.C. WainwrightMarch 31, 2023 | markets.businessinsider.comAcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate UpdateMarch 30, 2023 | finance.yahoo.comEarnings Outlook For AcelRx PharmaceuticalsMarch 29, 2023 | msn.comAcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023March 21, 2023 | finance.yahoo.comAcelRx Pharmaceuticals Shares Rise Premarket on Dsuvia Sale >ACRXMarch 14, 2023 | marketwatch.comAcelRx adds 16% on plans to divest pain therapyMarch 14, 2023 | msn.comAcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora PharmaceuticalsMarch 14, 2023 | finance.yahoo.comHere's Why AcelRx Pharmaceuticals (ACRX) Stock Gained TodayFebruary 24, 2023 | thestreet.comAcelrx PharmaceuticalsJanuary 18, 2023 | forbes.comAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call TranscriptDecember 29, 2022 | finance.yahoo.comAcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common StockDecember 27, 2022 | finance.yahoo.comThree Healthcare Penny Stocks to Watch In The New YearThese three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.December 27, 2022 | marketbeat.comThree Healthcare Penny Stocks to Watch In The New Year (ACRX)These three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.December 26, 2022 | marketbeat.comLooking Into AcelRx Pharmaceuticals's Return On Capital EmployedDecember 26, 2022 | benzinga.com Get AcelRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter. Email Address ACRX Media Mentions By Week ACRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACRX News Sentiment▼0.001.03▲Average Medical News Sentiment ACRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACRX Articles This Week▼00▲ACRX Articles Average Week Get AcelRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PMV Pharmaceuticals News Today Assertio News Today Kronos Bio News Today Medicus Pharma News Today BeyondSpring News Today Milestone Pharmaceuticals News Today FibroBiologics News Today Repare Therapeutics News Today Biodexa Pharmaceuticals News Today Oncolytics Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACRX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AcelRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AcelRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACRX Stock Free ACRX Stock Alerts